Anandhi Upendran, PhD

Director Biomedical Innovation

University of Missouri – Columbia (MU)

Nanoparticle based drug delivery system for drug resistant cancers, (OVARIAN, NSCLC)
Identifying and validating biomarkers for early Diabetic Retinopathy screening.